Raju Prasad, Chief Financial Officer at CRISPR Therapeutics AG (CRSP), sold 34,972 shares at $60.19 ($2.1M) on 2026-01-22, disclosed to the SEC on 2026-01-26.
Open-market sale of $2.1M CRSP by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CRSP | SELL | 2026-01-08 | $3.3M | — | Filing → |
| CRSP | SELL | 2025-12-23 | $1.1M | — | Filing → |
| CRSP | SELL | 2025-03-24 | $181K | — | Filing → |